Experts have said that the growing use of artificial lawns that does not require much maintenance, is posing a grave risk to wildlife and rare plants.
Conservationists and gardening experts have warned that the growing use might impact wildlife and rare plants as wildlife often use gardens after being forced from the countryside by loss of habitat and intensive farming. However, the popularity of artificial lawns that appears to be real but do not require mowing, watering or fertilising, is leaving no refuge for the wildlife across the UK.
Experts say that a growing number of people are opting for artificial lawns as it is really easy to maintain. The quality of artificial lawns has improved so much that often it is difficult to tell the difference between them and this has resulted in an increased demand. These manufactured lawns provide gardeners with an amazingly neat plot that requires no mowing, watering or fertilizing. Sellers have said that they have recorded a rise in demand for the gardens.
Experts warn that if the popularity continues to rise, it will impact bird, insect and mammal populations across the country.
Monohm Inc.’s incredibly weird circular smartphone-cum-pocket-watch -- called ‘Runcible’ -- is now available for preorders on the Indiegogo crowdfunding platform. The preorder window for the handset will close on June 30; and the first batch of...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an apparent attempt to enhance the visual experience for Google search users carrying out...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
Monohm Inc.’s incredibly weird circular smartphone-cum-...
OnePlus has announced that its latest flagship handset...
In an announcement made on Tuesday, social network...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).